Biogen Cuts Price Of Its Alzheimer’s Drug By 50%
Following reporting slower than expected sales for its Alzheimer’s drug in the United States as hospitals complained that the price of the drug was too high and its benefits did not meet the costs, Biogen Inc dropped the price of the drugs by about 50 per cent to $28,200 for an average weight person. The…









